ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

RDY Dr Reddys Laboratories Ltd

70.84
-0.86 (-1.20%)
2024年6月19日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Dr Reddys Laboratories Ltd RDY NYSE 普通株式
  前日比 前日比 % 現在値 時刻
-0.86 -1.20% 70.84 09:00:00
始値 安値 高値 終値 前日終値
71.51 70.52 71.64 70.84 71.70
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/1821:54EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/6/1422:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/6/1419:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/6/1319:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/6/1306:05EDGAR2Form 20-F - Annual and transition report of foreign private..
2024/6/1302:04EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/6/1019:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/6/0803:45EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/6/0723:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/6/0521:35EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/6/0421:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/6/0406:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/6/0402:05BWAurigene Pharmaceutical Services Limited, a Global CRDMO,..
2024/6/0319:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/3120:27EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/3100:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/3100:17EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/2919:18EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/2822:53BWDr. Reddy's Laboratories Announces the Appointment of Milan..
2024/5/2820:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/2502:58EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/2502:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/2302:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/2123:59EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/2123:49EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/2123:05BWAlvotech and Dr. Reddy’s Enter Into Collaboration for..
2024/5/2121:00GLOBEAlvotech and Dr. Reddy’s enter into collaboration for..
2024/5/1722:21EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/1603:36EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/1404:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/1319:33EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/0901:23EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/0819:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/0803:37EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/0723:31BWDr. Reddy’s Q4 & Full Year FY24 Financial Results
2024/5/0719:09EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/5/0321:00BWDr. Reddy's Laboratories Announces the Launch of Doxycycline..
2024/3/2220:00GLOBEPharmazz Inc. and Dr. Reddy's Laboratories have entered into..
2024/3/1920:00BWDr. Reddy's Laboratories launches Versavo® (bevacizumab) in..
2024/3/0420:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/3/0120:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2920:57EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2920:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2620:41EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2320:22EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2122:43EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/2020:20EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/1520:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/1302:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/2/0600:53EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..

最近閲覧した銘柄

Delayed Upgrade Clock